News
-
-
-
PRESS RELEASE
Electric Royalties Announces Marketing Activities and Long-Term Incentive Grants
Electric Royalties Ltd. announces marketing activities to increase investor awareness and grants stock options, RSUs, and DSUs. The Company aims to acquire royalties over commodities driving the electric revolution -
PRESS RELEASE
REMINDER: Jaguar Health Hosting April 30 Investor Webcast to Present Initial Results from Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health investor webcast to review crofelemer impact on MVID and SBS-IF patients. No approved treatments for MVID, study presented by Dr. Miqdady at ELITE PED-GI Congress -
PRESS RELEASE
Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
Abivax completes enrollment for Phase 3 ABTECT Trials in patients with active ulcerative colitis. Top-line results expected in Q3 2025, NDA submission planned for H2 2026 -
PRESS RELEASE
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
GENFIT announces filing of 2024 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, available for public viewing and download. Details of reports and company's focus on liver disease research and development highlighted -
-
-
PRESS RELEASE
EQS-Adhoc: aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024
aap Implantate AG postpones the publication of its 2024 annual and consolidated financial statements due to auditor delay and resource constraints. New deadline set for June 2025 -
